Victoria Ameral to Opioid-Related Disorders
This is a "connection" page, showing publications Victoria Ameral has written about Opioid-Related Disorders.
Connection Strength
2.116
-
Ameral V, Hickey TR, Reilly ED, Patterson JA, Sofuoglu M. Pharmacological and behavioral pain treatment strategies for patients with opioid use disorder. Expert Opin Pharmacother. 2025 Jun; 26(9):1041-1054.
Score: 0.571
-
Ameral V, Hocking E, Leviyah X, Newberger NG, Timko C, Livingston N. Innovating for real-world care: A systematic review of interventions to improve post-detoxification outcomes for opioid use disorder. Drug Alcohol Depend. 2022 04 01; 233:109379.
Score: 0.457
-
Ameral V, Palm Reed KM. Envisioning a future: Values clarification in early recovery from opioid use disorder. J Subst Abuse Treat. 2021 02; 121:108207.
Score: 0.418
-
Mandavia AD, Fonda JR, Banducci AN, Ameral VE, Sistad Hall RE, Loeffel LB, Roth CE, Simpson TL, Stein MD, Marx BP, Hyde J, Davenport M, Meng F, Livingston NA. Sex and race-ethnicity influences on opioid overdose deaths among veterans diagnosed with opioid use disorder between 2016 and 2021. Drug Alcohol Depend. 2025 Sep 01; 274:112764.
Score: 0.144
-
Mandavia AD, Banducci AN, Simpson TL, Marx BP, Hawn SE, Hyde J, Ameral VE, Sistad Hall RE, Roth CE, Sarpong AA, Davenport M, Meng F, Stein MD, Livingston NA. Sex Differences in Suicide, Lethal Means, and Years of Potential Life Lost Among Veterans With Substance Use Disorder. Womens Health Issues. 2025 May-Jun; 35(3):196-204.
Score: 0.141
-
DeVito EE, Ameral V, Sofuoglu M. Sex differences in comorbid pain and opioid use disorder: A scoping review. Br J Clin Pharmacol. 2024 Dec; 90(12):3067-3083.
Score: 0.136
-
Shirk SD, Ameral V, Kraus SW, Houchins J, Kelly M, Pugh K, Reilly E, Desai N. Buprenorphine Naloxone and Extended Release Injectable Naltrexone for the Treatment of Opioid Use Disorder Among a Veteran Patient Sample: A?Retrospective Chart Review. J Dual Diagn. 2021 Jul-Sep; 17(3):207-215.
Score: 0.109
-
Livingston NA, Ameral V, Banducci AN, Weisberg RB. Unprecedented need and recommendations for harnessing data to guide future policy and practice for opioid use disorder treatment following COVID-19. J Subst Abuse Treat. 2021 03; 122:108222.
Score: 0.105
-
Pope E, Ameral V, Falc?n A, Smith J, Shoemaker-Hunt SJ, Bounthavong M, McCullough M, Kim B. Knowledge and attitudes regarding substance use disorder treatment and harm reduction practices among US pharmacists: A scoping review. J Am Pharm Assoc (2003). 2025 Sep-Oct; 65(5):102462.
Score: 0.036